Benefits and risks evaluation of recombinant human growth hormone replacement therapy in children with GHD after craniopharyngioma surgery.

Li-Li PeiYing GuoMaria Eugenia SabatinoLi-Yong Zhong

Published in: Journal of pediatric endocrinology & metabolism : JPEM (2023)

GHRT effectively accelerates GV, increases HtSDS, and improves lipid profiles without unfavorable effects on glucose metabolism. The benefits are clear and the risks of adverse events are low.

Keyphrases

replacement therapy
growth hormone
recombinant human
human health
smoking cessation
minimally invasive
coronary artery bypass
young adults
risk assessment
fatty acid
coronary artery disease
percutaneous coronary intervention